Pregled bibliografske jedinice broj: 181369
Radiotherapy of stage IEA primary breast lymphoma: case report
Radiotherapy of stage IEA primary breast lymphoma: case report // Croatian medical journal, 43 (2002), 5; 569-572 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 181369 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Radiotherapy of stage IEA primary breast lymphoma: case report
Autori
Juretic, Antonio ; Zivkovic, Mirko ; Samija, Mirko ; Bagovic, Damir ; Purisic, Anka ; Viculin, Tomislav ; Bistrovic, Matija ; Stanec, Mladen ; Juzbasic, Stjepan ; Lesar, Mislav ; Tomek, Rudolf
Izvornik
Croatian medical journal (0353-9504) 43
(2002), 5;
569-572
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
non Hodgkin lymphomas; dojka; radioterapija; tangencialno polje zračenja
(non-Hodgkin lymphomas; breast; radiotherapy; tangential field irradiation)
Sažetak
A 47-year-old woman was referred for the treatment to our Hospital because of a palpable nodule in the upper medial quadrant of her right breast. After tumor excision, pathohistological examination showed a follicular center cell lymphoma grade 2, B-cell type (CD20+, bc16+, CD10+, bcl2+). The final diagnosis was stage IEA primary extranodal non-Hodgkin s breast lymphoma. The involved breast was irradiated isocentrically with two opposite 6-megavolt (MeV) photon beams delivered from the linear accelerator (tangential fields) using asymmetric collimator opening. Radiation volume, inclinations of the medial and lateral field, and the part of the underlying chest wall and lung parenchyma were determined during the radiotherapy simulation process. The total irradiation dose was 44 Gy delivered in single daily doses of 2 Grays (Gy). After breast photon irradiation, a boost to the tumor bed was performed by a direct 12 MeV electron beam, with a total dose of 6 Gy delivered over three days. Since primary non-Hodgkin lymphoma of the breast is rather rare, there has been no uniform approach to its treatment. The advantage of applying the asymmetric collimator jaw opening in breast radiotherapy is the instant reduction of the dose at margin fields, resulting in both the protection of neighboring lung parenchyma and the good coverage of planned target volume.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za tumore
Profili:
Rudolf Tomek
(autor)
Tomislav Viculin
(autor)
Matija Bistrović
(autor)
Stjepan Juzbašić
(autor)
Mirko Šamija
(autor)
Antonio Juretić
(autor)
Mladen Stanec
(autor)
Mirko Živković
(autor)
Damir Bagović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE